Publicaties 2019

  • Minnema LA, Giezen TJ, Gardarsdottir H, Egberts TCG, Leufkens HGM, Mantel-Teeuwisse AK. Post-marketing dosing changes in the label of biologicals. Br J Clin Pharmacol. 2019 Apr;85(4):715-721. doi: 10.1111/bcp.13843.
  • Vermeer NS, Giezen TJ, Zastavnik S, Wolff-Holz E, Hidalgo-Simon A. Identifiability of Biologicals in Adverse Drug Reaction Reports Received From European Clinical Practice. Clin Pharmacol Ther. 2019 Apr;105(4):962-969. doi: 10.1002/cpt.1310
  • Pereboom M, Mulder IJ, Verweij SL, van der Hoeven RTM, Becker ML. A clinical decision support system to improve adequate dosing of gentamicin and vancomycin. Int J Med Inform. 2019 Apr;124:1-5. doi: 10.1016/j.ijmedinf.2019.01.002.
  • Minnema LA, Giezen TJ, Souverein PC, Egberts TCG, Leufkens HGM, Gardarsdottir H. Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study. Drug Saf. 2019 Jul;42(7):887-895. doi: 10.1007/s40264-018-00789-9.
  • Becker ML, Baypinar F, Pereboom M, Lilih S, Kingma HJ, van der Hoeven RTM. Het positieve effect van klinische beslisregels getoond op het moment van voorschrijven. Nederlands Platform voor Farmaceutisch Onderzoek. 2019;4:a1717.